Nestle's Nine-Month Organic Sales Growth Missed Expectations—Update
By Giulia Petroni
Nestle posted a lower-than-expected organic sales growth in the first nine months of the year and confirmed its outlook.
The Swiss food and beverage giant said sales stood at 68.83 billion Swiss francs ($76.57 billion) in the period from CHF69.13 billion a year earlier. Sales grew 7.8% organically, missing a company-compiled consensus estimate of 8.1%.
Organic growth was driven by pricing at 8.4%, while real internal growth--the sum of volume and mix--came in line with expectations at minus 0.6%.
"Growth was driven by pricing as we continued to navigate historic inflation levels. The recovery of our volume and mix is underway," Chief Executive Mark Schneider said.
Nestle said it expects real internal growth to turn positive in the second half.
The company confirmed its full-year guidance for organic sales growth of between 7% and 8%, and underlying trading operating profit margin between 17% and 17.5%. Underlying earnings per share in constant currency are expected to increase between 6% and 10%.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
October 19, 2023 02:17 ET (06:17 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters